Learning to think with the end in mind will help clients and their selected CRO to design and conduct the right studies.
Michael V. Templin, PhD, DABT
Advertisement
Michael V. Templin, PhD, DABT is senior scientific director, Scientific Advisory Services at Charles River.
Articles by Michael V. Templin, PhD, DABT
Advertisement
Latest Updated Articles
Outsourcing of Nonclinical Studies for Drug Development: Tips and TrendsPublished: October 1st 2019 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
2
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
3
Everything to Know About Cell and Gene Therapy in 2025
4
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
5
